Professor Neal Navani

Neal Navani qualified in medicine from Cambridge and UCL in 2000 with distinction and several university prizes. He trained in respiratory medicine at the Brompton and Hammersmith Hospitals before winning a Medical Research Council fellowship in 2008 and completing his PhD at UCL in 2011.

He has also completed an MSc in clinical trials and biostatistics at the London School of Hygiene and Tropical Medicine.  

Professor Navani is lead clinician for the lung cancer services at UCLH, senior clinical lead of the UK National Lung Cancer Audit and is the respiratory representative on the current NICE lung cancer guideline and quality standards. He is the clinical director of lung cancer screening in North Central London and is co-chair of the national guideline on management of lung nodules. 

He has many national and international roles including the steering committee of the British Thoracic Oncology Group, the national lung cancer clinical expert group and is a director of the UK lung cancer coalition.  

Professor Navani also has a large research portfolio. He is lead investigator on >£3m of grant funding including the use of AI in predicting cancer prognosis and early detection of lung cancer including in people who have never smoked. He is the also the global co-chief investigator of a trial of robotic bronchoscopy.